ch505w100
Vaccineexperimental
Clinical trial activity
6 trials · 13 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 22, 2017 (NCT03220724)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06680479 | Phase 1 | Feb 15, 2025 | Access to Advanced Health Institute (AAHI), Duke University, National Institute of Allergy and Infectious Diseases (NIAID), University of Pittsburgh |
| NCT06557785 | Phase 1 | Nov 7, 2024 | Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) |
| NCT06267872 | Phase 1 | Oct 7, 2024 | Access to Advanced Health Institute (AAHI), Department of Health and Human Services, Duke University, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) |
| NCT06205056 | Phase 1 | Jan 31, 2024 | Duke University, Henry M. Jackson Foundation for the Advancement of Military Medicine, Janssen Pharmaceutica NV, Makerere University, National Institute of Allergy and Infectious Diseases (NIAID), United States Army |
| NCT04915768 | Phase 1 | May 3, 2021 | Harvard University, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT03220724 | Phase 1 | Aug 22, 2017 | Columbia University, National Institute of Allergy and Infectious Diseases (NIAID), University of Rochester |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (13)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 6 | 5 | 1 | 2017 |
| Duke University | Academic/Hospital | 3 | 0 | 1 | 2024 |
| Access to Advanced Health Institute (AAHI) | Academic/Hospital | 2 | 0 | 1 | 2024 |
| Department of Health and Human Services | Government | 2 | 0 | 1 | 2024 |
| National Institutes of Health (NIH) | Government | 2 | 0 | 1 | 2024 |
| Columbia University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Henry M. Jackson Foundation for the Advancement of Military Medicine | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Janssen Pharmaceutica NV | For profit | 1 | 0 | 1 | 2024 |
| Makerere University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| United States Army | Government | 1 | 1 | 1 | 2024 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2025 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2017 |
13 organizations
Page 1 / 1